GLI1 and acute myeloid leukemia: Zhou et al. reported that glioma-associated oncogene 1 (GLI1) enhanced the drug resistance of acute myeloid leukemia by regulating the cell cycle via the AKT/serine/threonine kinase glycogen synthesis kinase (GSK)/cyclin-dependent kinase (CDK) pathway [28].